Novo Nordisk says many Australians would be willing to pay the out-of-pocket costs for its blockbuster medicines, which can ...
Pharma group Hikma looks to take advantage as Novo Nordisk’s Wegovy and Ozempic start to go off patent next year ...
Hikma launched liraglutide, a generic version of an earlier Novo Nordisk weight loss drug, in the US in December. Liraglutide, which Novo sells as Victoza for diabetes and Saxenda for weight loss, has ...
Weight loss drugs like Ozempic, while transformative in combating obesity, have been linked to irreversible vision impairment ...
Blackstone, BlackRock, Apollo Global Management, Novo Nordisk A/S, Welltower, Prologis, and Venture Global are the seven Growth stocks to watch today, according to MarketBeat’s stock screener tool.
An increasing share of the population is living in retirement for longer periods of time, offering "specific market ...
Wall Street's major averages dipped for the week as investors wrestled with tariff twists from the Trump administration. The ...
The year 2024 has been a remarkable year for premier medical institution Asian Hospital and Medical Center (AHMC) as it fulfilled its promise to provide world class quality healthcare to more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results